WebDec 29, 2024 · Ethris has paved a new path from genes to therapeutic proteins, using its proprietary messenger RNA technology platform to discover, design and develop innovative therapies. With more than a … WebAt Ethris, we are working at the forefront of medical innovation and technology. To us, this is a once-in-a-lifetime chance, working on rethinking human therapeutics. ... It’s a plus, if you have been working in the biotech or pharma environment – but more importantly you are quick picking up on things and always willing to familiarize ...
€15M Cipla Investment - News ETHRIS
WebEthris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the … WebFeb 1, 2024 · Funding, Valuation & Revenue. 7 Fundings. Ethris's latest funding round was a Corporate Minority for $16M on December 29, 2024. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. the sopranos common sense media
Ethris sucht Senior Communications Manager (all genders are …
WebETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery. Planegg, Bayern, Germany 101-250 Corporate Round Private ethris.com/ 13,063 Highlights Total Funding Amount €79.8M Contacts 2 Employee Profiles 4 Investors 6 Similar Companies 12 Find More Contacts for ETHRIS Christian Plank CTO, Managing Director WebAug 22, 2024 · German biotech Ethris has hooked up with the MedImmune division of the big pharma AstraZeneca in a five-year deal to develop RNA therapies for respiratory … WebSep 15, 2024 · ETH47 is a therapeutic candidate that harbors the mRNA blueprint for type III interferon. It is designed to be administered directly to the respiratory tract to treat early infection caused by... the sopranos clothing